Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Gains from Investment Securities (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Gains from Investment Securities for 13 consecutive years, with $21.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities rose 335.72% year-over-year to $21.0 million, compared with a TTM value of $26.2 million through Dec 2025, up 498.83%, and an annual FY2025 reading of $26.2 million, up 498.83% over the prior year.
  • Gains from Investment Securities was $21.0 million for Q4 2025 at Tandem Diabetes Care, up from $8.7 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $107.5 million in Q1 2022 and bottomed at -$5.3 million in Q2 2025.
  • Average Gains from Investment Securities over 5 years is $8.0 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Gains from Investment Securities soared 632123.53% in 2022, then crashed 577.19% in 2023.
  • Year by year, Gains from Investment Securities stood at $15.0 million in 2021, then plummeted by 79.9% to $3.0 million in 2022, then crashed by 34.8% to $2.0 million in 2023, then surged by 144.04% to $4.8 million in 2024, then surged by 335.72% to $21.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for TNDM at $21.0 million in Q4 2025, $8.7 million in Q3 2025, and -$5.3 million in Q2 2025.